Comments on: Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency

Comments on: Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency https://medcitynews.com/2024/04/fda-approval-primary-immunodeficiency-whim-syndrome-rare-disease-x4-pharmaceuticals/ Healthcare technology news, life science current events Wed, 01 May 2024 05:12:16 +0000 hourly 1 https://wordpress.org/?v=6.5.3